Germany – Pharmaceutical products – Bekanntmachung vergebener Aufträge nach §130 c AGB V zu dem Arzneimittel Pegcetacopl
GWQ ServicePlus AG awarded €1 to Swedish Orphan Biovitrum GmbH for Healthcare & Medical in April 2026 — one of 207 awards this buyer has made, in line with its typical award size.
Buying agency
GWQ ServicePlus AGWinning supplier
Swedish Orphan Biovitrum GmbHContract description
Germany – Pharmaceutical products – Bekanntmachung vergebener Aufträge nach §130 c AGB V zu dem Arzneimittel Pegcetacoplan (Aspaveli)
Related awards · GWQ ServicePlus AG
207 awardsThe buyer's full award list ranked by value, with the winning supplier, date and sector on every row — plus CSV / API export.
- ocds-ted-131795-2026Novartis Pharma GmbH€125 Feb 2026 Healthcare
- ocds-ted-131852-2026neuraxpharm Arzneimittel GmbH€125 Feb 2026 Healthcare
- ocds-ted-133782-2026AstraZeneca GmbH€125 Feb 2026 Healthcare
Other wins · Swedish Orphan Biovitrum GmbH
4 winsThe supplier's complete win history across every buyer it sells to — not just the handful shown here.
- ocds-ted-363898-2026IKK classic€128 May 2026 Healthcare
- ocds-ted-415398-2026DAK-Gesundheit€117 Jun 2026 Healthcare
- ocds-ted-719763-2024IKK classic€126 Nov 2024 Healthcare
Premium · full dataset
See the full award context.
Competing bids, award margins and every related contract for GWQ ServicePlus AG and Swedish Orphan Biovitrum GmbH — one subscription unlocks everything.
Sign Up Free →Free account · cancel anytime · 14-day money-back